Secukinumab (Cosentyx):Secukinumab is an Interleucin-17A (IL-17A) inhibitor, initially developed and approved for the treatment of moderate to severe ...

Anemia in patients with HS is a multifaceted condition often driven by iron deficiency and chronic inflammation. Understanding the roles of ...

Xeljanz (Tofacitinib):Tofacitinib is a Janus kinase (JAK) enzyme inhibitor developed for the treatment of rheumatoid arthritis. It has also been ...

Hidradenitis suppurativa (HS) is a chronic skin disease characterized by painful bumps, abscesses, and scarring. Managing HS can be challenging, but ...

Hidradenitis Suppurativa Awareness Week also serves as a valuable platform to empower and support individuals and families affected by this challenging ...

Hidradenitis suppurativa (HS) is a complex and often misunderstood skin condition, shrouded in several ...